Krystal Biotech, Inc. (KRYS)
261.80
-0.87
(-0.33%)
USD |
NASDAQ |
Feb 20, 16:00
261.90
+0.10
(+0.04%)
After-Hours: 20:00
Krystal Biotech Price : 261.80 for Feb. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amicus Therapeutics, Inc. | 14.34 |
| DexCom, Inc. | 73.08 |
| Alkermes Plc | 31.91 |
| Regeneron Pharmaceuticals, Inc. | 779.67 |
| Alnylam Pharmaceuticals, Inc. | 336.19 |
Price Related Metrics
| PE Ratio | 38.25 |
| PS Ratio | 20.13 |
| PEG Ratio | 0.2964 |
| Price to Book Value | 6.225 |
| Price to Free Cash Flow | 41.47 |
| Earnings Yield | 2.61% |
| Market Cap | 7.592B |
| PEGY Ratio | 0.2964 |
| Operating PE Ratio | 48.62 |
| Normalized PE Ratio | 38.25 |